Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

May 08 • 04:00PM ET

121.29

+8.03 7.09 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARQT ANAB ZURA KRYS KYMR

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO IWC LFSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.17	Insider Own	27.89%	Shs Outstand	15.74M	Perf Week	-4.38%
Market Cap	1.74B	Forward P/E	-	EPS next Y	-6.52	Insider Trans	-0.47%	Shs Float	10.34M	Perf Month	-6.84%
Enterprise Value	1.50B	PEG	-	EPS next Q	-1.15	Inst Own	68.94%	Short Float	19.14%	Perf Quarter	47.55%
Income	-49.30M	P/S	-	EPS this Y	-49.54%	Inst Trans	25.09%	Short Ratio	6.48	Perf Half Y	60.12%
Sales	0.00M	P/B	8.22	EPS next Y	-17.44%	ROA	-28.73%	Short Interest	1.98M	Perf YTD	15.88%
Book/sh	14.76	P/C	6.64	EPS next 5Y	11.41%	ROE	-34.25%	52W High	151.18 -19.77%	Perf Year	426.43%
Cash/sh	18.26	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-106.76%	52W Low	20.20 500.45%	Perf 3Y	84.83%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.99% 5.96%	Perf 5Y	-21.44%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.94%	Oper. Margin	-	ATR (14)	8.60	Perf 10Y	-14.34%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.03	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	28.88	EPS Q/Q	-62.12%	SMA20	-4.37%	Beta	-0.11	Target Price	229.00
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-3.56%	Rel Volume	0.76	Prev Close	113.26
Employees	29	LT Debt/Eq	0.08	Earnings	May 07 BMO	SMA200	37.61%	Avg Volume	305.36K	Price	121.29
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.34% -	Trades		Volume	231,669	Change	7.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)